The store will not work correctly when cookies are disabled.
Piperidine-1-carbothioic acid (1-pyrazin-2-yl-ethylidene)-hydrazide
ID: ALA374548
PubChem CID: 9579564
Max Phase: Preclinical
Molecular Formula: C12H17N5S
Molecular Weight: 263.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C/C(=N\NC(=S)N1CCCCC1)c1cnccn1
Standard InChI: InChI=1S/C12H17N5S/c1-10(11-9-13-5-6-14-11)15-16-12(18)17-7-3-2-4-8-17/h5-6,9H,2-4,7-8H2,1H3,(H,16,18)/b15-10+
Standard InChI Key: IHPHTDJAZKAECG-XNTDXEJSSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
-2.9345 -6.4035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9356 -7.2308 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2209 -7.6436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5045 -7.2303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5073 -6.3999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2227 -5.9908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7894 -7.6416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7882 -8.4666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0757 -7.2281 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6393 -7.6394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3531 -7.2258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0681 -7.6371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3518 -6.4009 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.0656 -8.4626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7765 -8.8738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4928 -8.4638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4935 -7.6378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7779 -7.2221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 9 2 0
4 5 1 0
9 10 1 0
2 3 1 0
10 11 1 0
5 6 2 0
11 12 1 0
6 1 1 0
11 13 2 0
12 14 1 0
1 2 2 0
4 7 1 0
3 4 2 0
7 8 1 0
12 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 263.37 | Molecular Weight (Monoisotopic): 263.1205 | AlogP: 1.56 | #Rotatable Bonds: 2 |
Polar Surface Area: 53.41 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.78 | CX Basic pKa: 0.04 | CX LogP: 0.76 | CX LogD: 0.76 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.50 | Np Likeness Score: -1.87 |
References
1. Easmon J, Heinisch G, Holzer W, Rosenwirth B.. (1992) Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents., 35 (17): [PMID:1354751] [10.1021/jm00095a027] |
2. Kowol CR, Berger R, Eichinger R, Roller A, Jakupec MA, Schmidt PP, Arion VB, Keppler BK.. (2007) Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase., 50 (6): [PMID:17315858] [10.1021/jm0612618] |